Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Stromal Tumors × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 27 Carcinoma, Transitional Cell 25 Urinary Bladder Neoplasms 23 Neoplasms 20 Carcinoma, Merkel Cell 20 Carcinoma, Renal Cell 18 Neoplasm Metastasis 17 Colorectal Neoplasms 15 Breast Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 12 Ovarian Neoplasms 12 Triple Negative Breast Neoplasms 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Stomach Neoplasms 6 Melanoma 6 Recurrence 5 Prostatic Neoplasms 5 Carcinoma, Hepatocellular 5 Ureteral Neoplasms 4 Small Cell Lung Carcinoma 4 Neuroendocrine Tumors 4 Glioblastoma 4 Carcinoma, Squamous Cell 4 Uterine Cervical Neoplasms 3 Urethral Neoplasms 3 Turcot syndrome 3 Skin Neoplasms 3 Sarcoma 3 Lymphoma 3

Interventions

Imatinib Mesylate 64 Sunitinib 27 nilotinib 14 ripretinib 12 regorafenib 12 avapritinib 6 Dasatinib 5 spartalizumab 4 Laparoscopy 4 Ipilimumab 4 Blood Specimen Collection 4 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 4 pexidartinib 3 pazopanib 3 binimetinib 3 Temozolomide 3 Surveys and Questionnaires 3 Oxaliplatin 3 Observation 3 Nivolumab 3 Leucovorin 3 CTLA-4 Antigen 3 Biopsy 3 Bevacizumab 3 trametinib 2 tanespimycin 2 ponatinib 2 pembrolizumab 2 masitinib 2 famitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04258956 2025-09-11

AXAGIST

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡